Skip to main content
  • Saved

made a Post

Novavax Push For COVID-19 Vaccine Manufacturing Capacity Delays Flu Vaccine Application

Novavax Push For COVID-19 Vaccine Manufacturing Capacity Delays Flu Vaccine Application

Source : 'The Pink Sheet'

Manufacturing capacity shifting to COVID-19 vaccines is delaying Novavax, Inc.’s regulatory filings for its flu vaccine, CEO Stanley Erck said.

By Sarah Karlin-Smith